OptiNose, Inc. (OPTN)

USD 9.1

(0.33%)

Revenue Summary of OptiNose, Inc.

  • OptiNose, Inc.'s latest annual revenue in 2023 was 70.98 Million USD , down -6.93% from previous year.
  • OptiNose, Inc.'s latest quarterly revenue in 2024 Q2 was 20.49 Million USD , up 37.7% from previous quarter.
  • OptiNose, Inc. reported a annual revenue of 76.27 Million USD in annual revenue 2022, up 2.18% from previous year.
  • OptiNose, Inc. reported a annual revenue of 74.65 Million USD in annual revenue 2021, up 51.99% from previous year.
  • OptiNose, Inc. reported a quarterly revenue of 20.49 Million USD for 2024 Q2, up 37.7% from previous quarter.
  • OptiNose, Inc. reported a quarterly revenue of 19.82 Million USD for 2023 Q3, up 1.9% from previous quarter.

Annual Revenue Chart of OptiNose, Inc. (2023 - 2015)

Historical Annual Revenue of OptiNose, Inc. (2023 - 2015)

Year Revenue Revenue Growth
2023 70.98 Million USD -6.93%
2022 76.27 Million USD 2.18%
2021 74.65 Million USD 51.99%
2020 49.11 Million USD 41.83%
2019 34.63 Million USD 390.18%
2018 7.06 Million USD 0.0%
2017 - USD -100.0%
2016 47.5 Million USD 55782.35%
2015 85 Thousand USD 0.0%

Peer Revenue Comparison of OptiNose, Inc.

Name Revenue Revenue Difference
Collegium Pharmaceutical, Inc. 566.76 Million USD 87.475%
Embecta Corp. 1.12 Billion USD 93.666%
ANI Pharmaceuticals, Inc. 486.81 Million USD 85.418%
Dynavax Technologies Corporation 232.28 Million USD 69.44%
Esperion Therapeutics, Inc. 116.33 Million USD 38.98%
Pacira BioSciences, Inc. 674.97 Million USD 89.483%
PainReform Ltd. - USD -Infinity%
Aquestive Therapeutics, Inc. 50.58 Million USD -40.338%
Sunshine Biopharma, Inc. 24.09 Million USD -194.64%
SCYNEXIS, Inc. 140.14 Million USD 49.346%
China SXT Pharmaceuticals, Inc. 1.92 Million USD -3580.949%
Cosmos Health Inc. 53.37 Million USD -32.992%
Journey Medical Corporation 79.18 Million USD 10.348%
Sunshine Biopharma, Inc. 24.09 Million USD -194.64%
Safety Shot Inc 202.67 Thousand USD -34925.904%
Alpha Teknova, Inc. 36.68 Million USD -93.509%
Intra-Cellular Therapies, Inc. 464.37 Million USD 84.713%
Bright Green Corporation 401.49 Thousand USD -17580.845%
Procaps Group, S.A. 409.92 Million USD 82.683%
Theratechnologies Inc. 81.76 Million USD 13.181%
Harrow Health, Inc. 130.19 Million USD 45.476%
Sonoma Pharmaceuticals, Inc. 12.73 Million USD -457.417%
Biofrontera Inc. 34.07 Million USD -108.35%
DURECT Corporation 8.54 Million USD -730.452%
Supernus Pharmaceuticals, Inc. 607.52 Million USD 88.315%
Cronos Group Inc. 88.84 Million USD 20.096%
Ironwood Pharmaceuticals, Inc. 442.73 Million USD 83.966%
Kala Pharmaceuticals, Inc. - USD -Infinity%
RedHill Biopharma Ltd. 6.51 Million USD -989.899%
Organogenesis Holdings Inc. 433.14 Million USD 83.611%
Guardion Health Sciences, Inc. 12.24 Million USD -479.554%
Cumberland Pharmaceuticals Inc. 39.55 Million USD -79.475%
Radius Health, Inc. 2.88 Billion USD 97.537%
Universe Pharmaceuticals INC 32.3 Million USD -119.715%
ProPhase Labs, Inc. 44.38 Million USD -59.938%
Phibro Animal Health Corporation 1.01 Billion USD 93.025%
Procaps Group S.A. 409.92 Million USD 82.683%
Alvotech 91.43 Million USD 22.363%
TherapeuticsMD, Inc. 1.3 Million USD -5352.151%
Viatris Inc. 15.42 Billion USD 99.54%
Rockwell Medical, Inc. 83.61 Million USD 15.1%
Aytu BioPharma, Inc. 81 Million USD 12.364%
SIGA Technologies, Inc. 139.91 Million USD 49.265%
Tilray Brands, Inc. 788.94 Million USD 91.002%
Lifecore Biomedical, Inc. 128.26 Million USD 44.654%
Shineco, Inc. 9.8 Million USD -624.22%
PetIQ, Inc. 1.1 Billion USD 93.558%
Regencell Bioscience Holdings Limited - USD -Infinity%
Incannex Healthcare Limited 12 Thousand USD -591458.333%
Neurocrine Biosciences, Inc. 1.88 Billion USD 96.238%
Alimera Sciences, Inc. 80.75 Million USD 12.095%
Silver Spike Investment Corp. 11.72 Million USD -505.581%
Assertio Holdings, Inc. 152.06 Million USD 53.319%
Shuttle Pharmaceuticals Holdings, Inc. - USD -Infinity%
Petros Pharmaceuticals, Inc. 5.82 Million USD -1119.208%
Clever Leaves Holdings Inc. 17.41 Million USD -307.573%
Cyclo Therapeutics, Inc. 1.07 Million USD -6494.823%
Avadel Pharmaceuticals plc 27.96 Million USD -153.86%
Hempacco Co., Inc. 4.04 Million USD -1654.656%
Talphera, Inc. 651 Thousand USD -10804.301%
Alvotech 91.43 Million USD 22.363%
Eagle Pharmaceuticals, Inc. 316.61 Million USD 77.579%
Lantheus Holdings, Inc. 1.29 Billion USD 94.524%
Currenc Group, Inc. 53.25 Million USD -33.296%
Kamada Ltd. 144.75 Million USD 50.962%
Indivior PLC 1.09 Billion USD 93.505%
Evoke Pharma, Inc. 5.18 Million USD -1270.239%
Flora Growth Corp. 76.07 Million USD 6.683%
Cyclo Therapeutics, Inc. 1.07 Million USD -6494.823%
Evolus, Inc. 202.08 Million USD 64.873%
HUTCHMED (China) Limited 837.99 Million USD 91.529%
Amphastar Pharmaceuticals, Inc. 644.39 Million USD 88.984%
Akanda Corp. 2.16 Million USD -3186.356%